For patient investors, a turnaround for Janus Fund may be worth the wait as well, according to Morningstar analyst Brian Portnoy. In he recent report, he notes that despite recent blowouts in holdings such as Tyco and Tenet Healthcare, Janus Fund remains a "decent option" for large-growth exposure. "It's bull-market performance and sufficiently solid showings during bear-market growth rallies indicate the fund should stay in the hunt when the market one day smiles again on growth-oriented investing."

First « 1 2 3 » Next